Ty21 Based Vaccines for Cancer Development Services
The Ty21 vaccine, an active immunization against typhoid fever, is derived from a strain of Salmonella. While primarily utilized for typhoid prevention, research suggests potential therapeutic benefits of the Ty21 vaccine for select cancer types. Alfa Cytology specializes in cancer vaccine development services, offering high-quality Ty21 vaccines tailored to your specific cancer needs.
Ty21 Based Vaccines for Cancer
The Ty21 vaccine, an oral immunization for typhoid fever prevention, is derived from a live attenuated strain of Salmonella typhi. Recent studies have demonstrated that Ty21, beyond its typhoid prevention function, suppresses bladder cancer tumors while exhibiting a safer profile with fewer toxic side effects.
Studies conducted in mice revealed enhanced survival and diminished bladder inflammation following Ty21 administration. The introduction of Ty21 prompts the infiltration of crucial immune cells such as T-cells, natural killer cells, and myeloid cells, pivotal for the regression of bladder tumors. Alongside its significant role in bladder cancer suppression, the Ty21 vaccine has been engineered to express the L1 protein of HPV16, inducing neutralizing antibodies in mice while preserving its original typhoid prevention function. These findings suggest the potential application of the Ty21 vaccine as part of a combination vaccine strategy.
Our Service
Ty21 vaccines are believed to strengthen the body's anti-tumor immune response, potentially halting tumor growth and spread, thus improving overall survival rates. Alfa Cytology offers expert support services from a highly specialized team for advancing Ty21 vaccines against cancer.
Application of Ty21 Vaccines
The investigation into Ty21 vaccines for cancer prevention remains somewhat limited, yet experimental findings have exhibited promising potential. Here are several instances of research on Ty21 vaccines in cancer therapy.
HPV is responsible for the prevalent cases of cervical cancer in developing nations, particularly high-risk strains like type 16, which account for 70% of cervical cancer cases. A recombinant oral vaccine has been investigated to inhibit the development of cervical cancer by targeting the L1 protein of HPV16 integrated into the Ty21 vector. Alfa Cytology provides Ty21 vaccines tailored for cervical cancer.
Previous research has shown that administering an appropriate dose of Ty21 reduces bladder inflammation, induces apoptosis in urinary tract epithelial tumor cells, and improves survival rates in mice with bladder tumors. These findings highlight the therapeutic potential of Ty21 in bladder cancer. Alfa Cytology offers customized Ty21 vaccines specifically designed for bladder cancer treatment.
Ty21 Based Vaccine Development Processes
Genetic Modification
Expression and Preparation
Quality Control
Testing the vaccine's quality.
Assessing safety and efficacy in preclinical studies.
Why Choose Us?
Professional and well-trained technical team.
Advanced experimental equipment.
Empowering success through cooperation.
Strict quality control system.
Benefiting from the Ty21 vaccine's involvement in the inflammatory response and its enhanced safety profile, Alfa Cytology, a specialized provider of cancer vaccine development services, offers expert guidance for your Ty21 vaccine development endeavors tailored to cancer treatment. Should you have any inquiries about this matter, please do not hesitate to contact us. We are committed to offering you professional service and support.